Abstract
Since mitochondrial factors have been implicated in apoptosis, experiments were designed to assess whether or not the potent mitochondrial nuclease could be one of these factors. Nuclei isolated by two different methods were found to contain mitochondrial nuclease in masked form. This nuclease was released by treatment with the non-ionic detergent NP-40 and rendered trypsin-sensitive. It was not removed appreciably from the nuclei by washing and sedimentation of the nuclei through a sucrose cushion. Levels of the mitochondrial nuclease were followed during drug-induced apoptosis. Time courses of apoptosis in cultures of HL-60 cells were monitored by flow cytometry of propidium iodide-stained cells and by agarose gel electrophoresis of extracted DNA. Changes in the inner mitochondrial transmembrane potential were monitored by flow cytometry of chloromethyl-X-Rosamine-stained cells. Apoptosis was induced by treatment with either the chemotherapeutic agent etoposide (VP-16 at 10 μM) over an 8 h period or with the anti-rheumatic agent hydroxychloroquine (HCQ at 0.28 mM) over a 24 h period. These two drugs likely act in different pathways of apoptosis. VP-16 caused loss of the mitochondrial transmembrane potential 1.0–1.5 h before apoptosis was detected. On the other hand, treatment with HCQ caused these processes to occur in parallel possibly indicating that the mitochondrial changes are secondary events. No losses of masked mitochondrial nuclease were detected with either drug treatment during the course of apoptosis. HL-60 mitochondrial DNA was also not degraded during apoptosis induced by either agent. These observations likely explain why the mitochondrial DNA is not degraded and make it unlikely that mitochondrial nuclease plays any role in vivo in chromatin DNA fragmentation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fraser MJ, Low RL. Fungal and mitochondrial nucleases. In: Roberts RJ, Linn SM, Lloyd RS, eds. Nucleases, Second Edition. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory Press, 1993: 171–207.
Cummings OW, King TC, Holden JA, Low RL. Purification and characterization of the potent endonuclease in extracts of bovine heart mitochondria. J Biol Chem 1987; 262: 2005– 2015.
Cote J, Renaud J, Ruiz-Carillo A. Recognition of (dG)n.(dC)n sequences by endonuclease G. Characterization of the calf thymus nuclease. J Biol Chem 1989; 264: 3301–3310.
Cote J, Ruiz-Carillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science 1993; 261: 765– 769.
Gerschenson M, Houmiel KL, Low RL. Endonuclease G from mammalian nuclei is identical to the major endonuclease of mitochondria. Nucl Acids Res 1995; 23: 88–97.
Dake E, Hofmann TJ, McIntire S, Hudson A, Zassenhaus HP. Purification and properties of the major nuclease from mitochondria of Saccharomyces cerevisiae. J Biol Chem 1988; 263: 7691–7702.
Ikeda S, Hasegawa H, Kaminaka S. A 55-kDa endonuclease of mammalian mitochondria: Comparison of its subcellular localization and endonucleolytic properties with those of endonuclease G. Acta Med Okayama 1997; 51: 55–62.
Murgia M, Pizzo P, Sandona D, Zanovello P, Rizzuto R, Di Virgilio F. MitochondrialDNAis not fragmented during apoptosis. J Biol Chem 1992; 267: 10939–10941.
Tepper CG, Studzinski GP. Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res 1992; 52: 3384– 3390.
Susin SA, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184: 1331–1341.
Susin SA, Zamzami N, Castedo M, et al. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Exp Med 1997; 186: 25–37.
Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996; 86: 147–157.
Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATPdependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489.
Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17: 37–49.
De Vos K, Gossens V, Boone E, et al. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem 1998; 273: 9673– 9680.
Walker PR, Sikorska M. New aspects of the mechanism of DNA fragmentation in apoptosis. Biochem Cell Biol 1997; 75: 287–299.
Fraser MJ, Tynan SJ, Papaioannou A, Ireland CM, Pittman SM. Endo-exonuclease of human leukaemic cells: evidence for a role in apoptosis. J Cell Sci 1996; 109: 2343–2360.
Enari M, Sakahira H, Yokoyama K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50.
Martins LM, Mesner PW, Kottke TJ, et al. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1997; 90: 4283–4296.
Saeki K, Akira Y, Kato M, Miyazono K, Yakazaki Y, Takaku F. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor b1 and overexpression of Bcl-2. J Biol Chem 1997; 272: 20003–20010.
Xiang J, Chao DT, Korsmeyer SJ. Bax-induced cell death may not require interleukin 1b-converting enzyme-like proteases. Proc Natl Acad Sci USA 1996; 93: 14559–14563.
Adjei PN, Kaufmann SH, Leung W-Y, Mao F, Gores GJ. Selective induction of apoptosis in Hep 3B cells by topoisomerase inhibitors: Evidence for a protease-dependent pathway that does not activate cysteine protease P32. J Clin Invest 1996; 98: 2588–2596.
Lavoie JN, Nguyen M, Marcellus, RC, Branton PE, Shore GC. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by z-VAD-fmk. J Cell Biol 1998; 140: 637–645.
Meng XW, Feller JM, Ziegler JB, Pittman SM, Ireland CM. Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine. Arthritis Rheum 1997; 40: 927–935.
Macho A, Decaudin D, Castedo M, et al. Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry 1996; 25: 333–340.
Bogenhagen D, Clayton DA. The number of mitochondrial deoxyribonucleic acid genomes in mouse L and human HeLa cells. Quantitative isolation of mitochondrial deoxyribonucleic acid. J Biol Chem 1974; 249: 7991–7995.
Anderson A, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457–465.
Meinkoth J, Wahl G. Hybridization of nucleic acids immobilized on solid supports. Anal Biochem 1984; 138: 267–284.
Chauhan D, Pandey P, Ogata A, et al. Cytochrome c-dependent and-independent induction of apoptosis in multiple myeloma cells. J Biol Chem 1997; 272: 29995–29997.
Tang DG, Li L, Zhu Z, Joshi B. Apoptosis in the absence of cytochrome c accumulation in the cytosol. Biochem Biophys Res Commun 1998; 242: 380–384.
Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 1993; 300: 440–450.
Collins MKL, Furlong IJ, Malde P, Ascaso R, Oliver J, Rivas AL. An apoptotic endonuclease activated either by decreasing pH or by increasing calcium. J Cell Sci 1996; 109: 2393–2399.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meng, X.W., Fraser, M.J., Ireland, C.M. et al. An investigation of a possible role for mitochondrial nuclease in apoptosis. Apoptosis 3, 395–405 (1998). https://doi.org/10.1023/A:1009654418089
Issue Date:
DOI: https://doi.org/10.1023/A:1009654418089